Check out your Company Bowl for anonymous work chats.
Marketing Mix (MMx) modeling helps commercial teams measure and optimize promotional investments across different channels to maximize ROI and improve customer experience. This data-driven process utilizes sophisticated analytic models to evaluate the impact of each channel, empowering commercial teams to develop, simulate and optimize investment scenarios. It takes an omnichannel perspective, recognizing the importance of integrating various touchpoints to create a seamless and cohesive customer journey.
The omnichannel-driven approach to promotional activity is being shaped by evolving dynamics in the life sciences market: · The behavior of the target audience is changing. Customers have an increased desire for personalized content and on-demand access. · Proliferation of data and AI is introducing more complexity to planning, execution and adoption of new ways of doing things. · Economic pressures and fear of message fatigue are leading promotional efforts to become more orchestrated and cost-efficient. What considerations should life sciences organizations make as they strive to advance their omnichannel capabilities? Learn more with Susheel Sukhtankar, Partner and Head of Commercial Analytics, as he hosts a lively discussion featuring a panel of Trinity experts, who share perspectives on designing, implementing, measuring and optimizing within an omnichannel framework.
“From a global life sciences technology perspective, the power of Generative AI provides an opportunity to bring people without technical backgrounds into the leading edge of data science,” said Rajeev Rangachari, CTO of Trinity Life Sciences. “I am honored to lead Trinity’s technology strategy at such an exciting moment and look forward to bolstering an already innovative culture by enhancing and developing world-class tools and technology that support life sciences commercialization.”
Trinity Life Sciences ranked in the Vault Top 100 Best Internships! We also made the rankings for top consulting internships, diversity with respect to women, racial & ethnic diversity and overall diversity. To learn more about our internship program, visit the link!
The announcement was made at our Leadership Conference that Leslie Orne will take over as Trinity Life Sciences’ CEO on July 1. Hear her first comments after coming off the stage.
We want to take a moment to celebrate the remarkable journey of our current CEO, David Fitzhenry, who has dedicated over 25 years to Trinity Life Sciences. It is with great respect and admiration that we bid farewell to our esteemed leader as he embarks on a new chapter of his life in retirement. Dave’s tenure at Trinity has been nothing short of extraordinary. Over the years, he has exemplified exceptional leadership, unwavering dedication and a commitment to driving innovation and transformation in the life sciences industry. Under Dave’s leadership, Trinity has solidified its position as a trusted partner to life sciences companies worldwide. Beyond his accomplishments, Dave has been an incredible mentor and advocate. His belief in the power of people has created a work environment where innovation thrives, and employees are inspired to make a difference in the lives of patients globally. Dave won’t be far. He will continue to be a Strategic Advisor to the Company and have a seat on Trinity’s Board of Directors. Dave’s successor choice is Leslie Orne, who will be taking over as the new CEO of Trinity Life Sciences on July 1. Leslie has been with Trinity for over 20 years and brings a wealth of experience and expertise to her new role. With her strong leadership skills and strategic vision, we have no doubt that Trinity will continue to flourish and build upon its remarkable legacy. Read more about our new CEO, Leslie Orne, in our latest news release:
Happy PRIDE Month from Trinity! As we celebrate PRIDE this month, we also recognize the diverse history and continued challenges that the LGBTQIA+ community faces daily. At Trinity, we stand with our LGBTQIA+ employees around the globe, this month, and every month. In observance and celebration of PRIDE and the LGBTQIA+ community, we reaffirm our commitment to creating an inclusive environment where everyone can bring their authentic selves to work. Join us in celebrating Pride Month and let's continue to champion inclusivity and acceptance every day. Together, we can make a difference.
“There is both a science and an art to forecasting,” explained Susheel Sukhtankar, Partner and Head of Commercial Analytics at Trinity Life Sciences. “From long-range strategic forecasts to operational demand models, it is the integration of strategy, data, insights and analytics with cutting-edge technology that drives a rich, nuanced business story.” Read more about the enhancements to our cross-functional forecasting tool, Trinity CloudCast™ in our latest news release:
January/February 2023 Trinity Life Sciences' Intelligence Newsletter brings you the latest thought leadership in the form of advisory briefs, white papers, webinars and more. Live Webinar | February 23, 2023 | 1:00-1:45 PM ET Ambulatory Surgical Centers: How to Secure Commercial Targeting Success in 2023 Experts from Trinity Life Sciences’ MedTech team partner with guest speaker, Mayuri Shah from Bain & Co., to deliver insights drawn from real case studies to inform how your organization can strengthen its commercial targeting and engagement strategies for ambulatory surgical centers (ASCs). Register for this webinar to understand: • How ASC macrotrends are impacted by market events, procedure type, reimbursement and geography • How your organization can develop more informed commercial targeting and engagement strategies for ASCs to maximize product adoption, penetration and revenue • The implications and key considerations for MedTech organizations facing shifting procedures
March 2023 Trinity Life Sciences' Intelligence Newsletter brings you the latest thought leadership in the form of advisory briefs, white papers, webinars and more. Live Webinar | March 30, 2023 | 1:00 PM-1:45 PM ET Confident Contracting: Optimize and Accelerate Key Decisions with Tech-Enabled Impact Projections Developing and refining U.S. contract strategy and contract design is challenging. One of the most critical hurdles is evaluating the holistic direct and indirect impacts of contract decisions across multiple scenarios at speed and with precision. Achieving that comprehensive view drives clear guidance to pricing decision-makers and avoids costly mistakes. Join Monica Martin De Bustamante—Senior Partner & Head of Evidence, Value, Access & Pricing (EVAP), John Greenaway—EVAP Partner and Jennifer Boyce—EVAP Engagement Manager as they discuss tips and Trinity’s best practices to overcome key challenges facing contract decision-makers.
